rs20541, IL13;TH2LCRR

N. diseases: 52
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation BEFREE In contrast, the lack of any association between rs20541 (IL13) and psoriasis in our Egyptian cohort suggests the existence of important inter-ethnic genetic differences in psoriasis susceptibility. 25406098 2015
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation GWASCAT Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. 25903422 2015
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation GWASCAT Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. 26626624 2015
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation BEFREE In subgroup analyses, the two SNPs were significantly associated (P < 0.05) with type I psoriasis, Rs495337 showed statistically difference between positive family history of psoriasis patients and controls whereas rs20541 might preferentially associated with negative family history psoriasis patients. 23617596 2013
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation BEFREE Evidence for an association between EBV-negative cHL and rs20541 (5q31, IL13: OR = 1.53, 95% CI = 1.32 to 1.76, P = 5.4 x 10(-9)), a variant previously linked to psoriasis and asthma, was observed; however, the evidence for replication was less clear. 22286212 2012
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation BEFREE The minor allele T of rs20541 in IL13 is the risk allele for asthma but the protective allele for psoriasis. 22694930 2012
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation BEFREE The authors genotyped three groups of Caucasians: those with PsA, those with psoriasis without arthritis (PsC) and healthy controls for the rs20541 and rs848 IL13 single nucleotide polymorphisms (SNPs). 21613309 2011
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation GWASDB Association analyses identify six new psoriasis susceptibility loci in the Chinese population. 20953187 2010
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation GWASDB Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. 19169254 2009
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation GWASCAT Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. 19169254 2009
Psoriasis
CUI: C0033860
Disease: Psoriasis
0.860 GeneticVariation BEFREE A multitiered genetic association study of 25 215 single-nucleotide polymorphisms (SNPs) in three case-control sample sets (1446 patients and 1432 controls) identified three IL13-linked SNPs (rs1800925, rs20541 and rs848) associated with psoriasis. 18075513 2008
Hodgkin Disease
CUI: C0019829
Disease: Hodgkin Disease
0.810 GeneticVariation GWASDB A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014 2014
Hodgkin Disease
CUI: C0019829
Disease: Hodgkin Disease
0.810 GeneticVariation BEFREE We searched for an association between the interleukin 4 receptor gene (IL4R) rs1805015 and interleukin 13 gene (IL13) rs20541 polymorphisms and the development of antibodies to hepatitis B surface antigen (anti-HBs) in the case of hepatitis B virus (HBV) vaccination or infection in hemodialysis (HD) patients. 23462527 2013
Hodgkin Disease
CUI: C0019829
Disease: Hodgkin Disease
0.810 GeneticVariation GWASDB Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212 2012
Hodgkin Disease
CUI: C0019829
Disease: Hodgkin Disease
0.810 GeneticVariation GWASCAT Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212 2012
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation GWASCAT Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. 29273806 2018
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation BEFREE These results support the existence of a significant association between GSTP1 rs1695 and IL13 rs20541 SNPs, with susceptibility to asthma, in the population studied. 27561723 2018
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation BEFREE IL-13 minor T and A alleles for rs1295686 and rs20541, respectively, were associated with significantly higher risk of asthma in the Saudi Arabian population. 29211635 2018
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation GWASCAT Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. 29273806 2018
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation BEFREE Self-Reported Allergic Rhinitis and/or Allergic Conjunctivitis Associate with IL13 rs20541 Polymorphism in Finnish Adult Asthma Patients. 28273659 2017
Allergic Reaction
CUI: C1527304
Disease: Allergic Reaction
0.800 GeneticVariation GWASDB A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. 23817569 2013
Allergic Reaction
CUI: C1527304
Disease: Allergic Reaction
0.800 GeneticVariation GWASCAT A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. 23817569 2013
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation BEFREE ICSNPathway analysis identified four candidate causal SNPs, four genes, and 21 candidate causal pathways, which in total provided four hypothetical biologic mechanisms: (1) rs7192 (nonsynonymous coding) to HLA-DRA to 21 pathways, such as, the role of eosinophils in the chemokine network of allergy, Th1/Th2 differentiation, and asthma (nominal p ≤ 0.001, FDR p ≤ 0.01); (2) rs20541 (nonsynonymous coding) to IL13 to asthma and cytokines and inflammatory response (nominal p<0.001, FDR p ≤ 0.008); (3) rs1058808 (frameshift coding) to ERBB2 to transmembrane receptor activity (nominal p=0.001, FDR p=0.01); (4) rs17350764 (nonsynonymous coding (deleterious)) to OR52J3 to transmembrane receptor activity (nominal p=0.001, FDR p=0.01). 23200760 2013
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation BEFREE Evidence for an association between EBV-negative cHL and rs20541 (5q31, IL13: OR = 1.53, 95% CI = 1.32 to 1.76, P = 5.4 x 10(-9)), a variant previously linked to psoriasis and asthma, was observed; however, the evidence for replication was less clear. 22286212 2012
Asthma
CUI: C0004096
Disease: Asthma
0.800 GeneticVariation BEFREE To investigate associations between total serum immunoglobulin E (IgE) levels and single nucleotide polymorphisms (SNPs) from eight candidate genes (IL-4 rs2243250, IL-4Rα rs1805010, IL-13 rs20541, IL-13Rα1 rs2495636, CD14 rs2569190, tumor necrosis factor-alpha (TNF-α) rs1800629, cytotoxic T lymphocyte-associated antigen (CTLA4) rs231775, FCER1B rs1441585) in children with asthma and to evaluate gene-gene interactions. 22376040 2012